Biofrontera AG with new Corporate Website
(Thomson Reuters ONE) -
Biofrontera AG /
Biofrontera AG with new Corporate Website
. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
Leverkusen, Germany, 10 June 2013 - Biofrontera AG has redesigned its webpage
under www.biofrontera.com. Content, layout and the underlying content management
system have been structured more user-friendly and direct more rapidly to the
requested information. Along with the product launches of Ameluz(®), Belixos(®),
and BF-RhodoLED(®) separate product websites have been established.
Consequently, the corporate website focuses even more on company-specific
content and investor related topics. The separation of product-related and
business-related content illustrates Biofrontera's recent corporate development
to a specialty pharma company with own marketing and sales and is consistent
with the limitations of the German drug advertising law. The corporate website
is designed to provide clear information and rapid contacting for potential
investors and interested parties.
Biofrontera AG
Biofrontera aims at attending and treating the skin, recognizing the aesthetic
needs of a person's visual reflection.
Biofrontera AG is listed on the regulated market of the Frankfurt stock exchange
under the symbol B8F and the ISIN number DE0006046113.
www.biofrontera.com
This press release contains forward-looking statements based on the currently
held beliefs and assumptions of the management of Biofrontera AG, which are
expressed in good faith and, in their opinion, reasonable. Forward-looking
statements involve known and unknown risks, uncertainties and other factors,
which may cause the assumptions expressed or implied in this press release to be
faulty. Given these risks, uncertainties and other factors, recipients of this
document are cautioned not to place undue reliance on the forward-looking
statements. Biofrontera AG disclaims any obligation to update these forward-
looking statements to reflect future events or developments.
For further information please contact:
Anke zur Mühlen
Corporate Communication
+ 49 (0) 214 87632 22
+ 49 (0) 214 87632 90
a.zurmuehlen(at)biofrontera.com
Biofrontera AG
Hemmelrather Weg 201
D- 51377 Leverkusen, Germany
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Biofrontera AG via Thomson Reuters ONE
[HUG#1708184]
Unternehmensinformation / Kurzprofil:
Datum: 10.06.2013 - 09:30 Uhr
Sprache: Deutsch
News-ID 267889
Anzahl Zeichen: 3095
contact information:
Town:
Leverkusen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 160 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Biofrontera AG with new Corporate Website"
steht unter der journalistisch-redaktionellen Verantwortung von
Biofrontera AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
